Sessa Capital (Master), L.P. (CIK 1618360) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-01). Recent activity: Buy SABS (1.7M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-01 | SAB Biotherapeutics, Inc. (SABS) | Director | Buy | 1.7M | $3.0M |
Source: SEC Form 4 filings · as of 2025-10-01